Shared experiences in Oncology & Rare Diseases | Erin Moriarty Wade & James A. Geraghty

Описание: Meet biotech pioneer Jim Geraghty on our latest podcast! 🎙️

This new episode of “Shared Experiences in Oncology & Rare Diseases” features Jim Geraghty, a widely recognized leader in the rare disease field who has worked as a strategy consultant, a CEO, a leader pioneering international operations at Genzyme, and a venture entrepreneur.

Jim is also the author of a fascinating new book called “Inside the Orphan Drug Revolution.”

We discuss these topics and more:
How the Orphan Drug Revolution and rare disease advocacy began
Lessons learned from the Orphan Drug Revolution
The role of patients and families in the Orphan Drug Revolution in the past and today
Newborn screening and rare diseases
Rare disease clinical trials
Rare disease Expanded Access Programs (compassionate use)

You can find Jim’s book on Amazon at: https://www.amazon.com/Inside-Orphan-...

Learn more about Jim’s book and get in touch with him via his website: https://orphandrugrevolution.com/

About myTomorrows and the rare disease community
There are more than 7,000 rare diseases, and it is estimated that more than 90 percent of them still don’t have an approved treatment option. Our team has extensive experience in the rare disease field, having helped more than 2,517 rare disease patients and 789 physicians in 51 countries with searching for rare disease clinical trials or expanded access programs over the past three years. In addition, myTomorrows has also worked with 11 BioPharma clients the rare disease space.

Learn more about how myTomorrows helps BioPharma clients with clinical trials, Expanded Access and Real-World Data here: https://mytomorrows.com/en/pharma